INTC
Intel Corporation
INTC has the edge over ZENA overall, supported by stronger fundamentals and lower modeled downside.
ZENA
ZenaTech, Inc.
ZENA offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
INTC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Healthy | |
| Healthy |
INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.
ZENA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Weak |
ZENA's revenue is currently healthy, but its profitability, cash flow and balance sheet are weak.
INTC PE Valuation
INTC has no meaningful PE right now: it lost money over the past year.
ZENA PE Valuation
ZENA has no meaningful PE right now: it lost money over the past year.
INTC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Broad | |
| Low |
Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.
ZENA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect ZENA's losses to shrink, with revenue growing.
INTC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.41 | — |
| Q3 2026 | -$2.39 | -24000% |
| Q2 2026 | -$2.09 | +$2.68 |
| Q1 2026 | -$0.60 | +$3.88 |
| Q4 2025 | -$0.06 | +$4.32 |
| Q3 2025 | $0.01 | +$3.72 |
| Q2 2025 | -$4.77 | -2088% |
| Q1 2025 | -$4.48 | -562% |
| Q4 2024 | -$4.38 | -1195% |
INTC has the edge over ZENA on earnings, with more consistent year-over-year improvement.
ZENA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.41 | -$1.00 |
| Q1 2026 | -$1.34 | -$1.05 |
| Q4 2025 | -$0.93 | -$0.78 |
| Q3 2025 | -$0.62 | -$0.58 |
| Q2 2025 | -$0.41 | -$0.39 |
| Q1 2025 | -$0.29 | -$0.28 |
| Q4 2024 | -$0.15 | -$0.14 |
| Q3 2024 | -$0.04 | -$0.02 |
ZENA lost $1.41 per share over the past year, and its loss has widened in each of the last nine quarters.
INTC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16.5B | +21% |
| Q2 2026 | $16.1B | +25% |
| Q1 2026 | $13.6B | +7.2% |
| Q4 2025 | $13.7B | -4.1% |
| Q3 2025 | $13.7B | +2.8% |
| Q2 2025 | $12.9B | +0.2% |
| Q1 2025 | $12.7B | -0.4% |
| Q4 2024 | $14.3B | -7.4% |
INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +10 points |
| Q2 2026 | 11% | +36 points |
| Q1 2026 | -23% | -21 points |
| Q4 2025 | 4.2% | +1.4 points |
| Q3 2025 | 5% | +73 points |
| Q2 2025 | -25% | -9.4 points |
| Q1 2025 | -2.4% | +6 points |
| Q4 2024 | 2.9% | -14 points |
INTC has the edge over ZENA on profitability, with a higher operating margin.
ZENA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.5M | +314% |
| Q1 2026 | $6M | +652% |
| Q4 2025 | $3.6M | +671% |
| Q3 2025 | $3.1M | +1225% |
| Q2 2025 | $1.6M | +504% |
| Q1 2025 | $798.4K | +92% |
| Q4 2024 | $473.4K | -4.4% |
| Q3 2024 | $230.5K | +23% |
ZENA has the edge over INTC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -235% | -60 points |
| Q1 2026 | -257% | +6.8 points |
| Q4 2025 | -262% | +97 points |
| Q3 2025 | -101% | +61 points |
| Q2 2025 | -174% | -149 points |
| Q1 2025 | -263% | -269 points |
| Q4 2024 | -359% | -420 points |
| Q3 2024 | -162% | -131 points |
ZENA's operating margin was −235% last quarter, down 60 points from the same quarter a year ago.
INTC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +774% |
| Q2 2026 | $4.5B | +$6B |
| Q1 2026 | -$2.5B | +$1.8B |
| Q4 2025 | $800M | +$3.5B |
| Q3 2025 | $121M | +$2.5B |
| Q2 2025 | -$1.5B | +$1.9B |
| Q1 2025 | -$4.4B | +$2.8B |
| Q4 2024 | -$2.7B | -$597M |
INTC has the edge over ZENA on cash generation, producing positive trailing cash flow while its opponent burns cash.
ZENA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$18.9M | -$13.7M |
| Q1 2026 | -$14.9M | -$10.9M |
| Q4 2025 | -$14.2M | -$10M |
| Q3 2025 | -$5.9M | -$4.3M |
| Q2 2025 | -$5.2M | -$4.9M |
| Q1 2025 | -$4M | -$3.7M |
| Q4 2024 | -$4.2M | -$2.8M |
| Q3 2024 | -$1.6M | -679% |
ZENA has burned cash in almost every quarter: −$54M over the past year, against −$15M the year before.
INTC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4% | +203M shares |
| 1 year | +17% | +776M shares |
| 3 years | +25% | +1.1B shares |
| 5 years | +30% | +1.2B shares |
| Available history | +19% | +834M shares |
INTC has the edge over ZENA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | $114M |
| Q1 2021 | $2.3B |
ZENA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +137% | +46.8M shares |
| 1 year | +156% | +49.3M shares |
| 3 years | +381% | +64.1M shares |
ZENA has 81M diluted shares, up 156% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ZENA hasn't bought back shares in the past year.
INTC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Healthy |
| Q2 2026 | 3.1x | Elevated |
| Q1 2026 | 3.9x | Elevated |
| Q4 2025 | 3.4x | Elevated |
| Q3 2025 | 4.0x | Elevated |
| Q1 2025 | 69.6x | High |
| Q3 2024 | 23.8x | High |
| Q2 2024 | 4.3x | High |
INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
ZENA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2024 | 81.3x | High |
| Q2 2024 | 17.6x | High |
| Q1 2024 | 16.8x | High |
| Q4 2023 | 17.2x | High |
| Q3 2023 | 46.4x | High |
| Q2 2023 | 17.0x | High |
| Q1 2023 | 0.0x | Very low |
| Q4 2022 | 8.4x | High |
ZENA's net debt is more than 20 years of its operating earnings (EBITDA), up from more than 20 years a year ago.
INTC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.1 | Neutral |
| Stochastic | 7.7 | Oversold |
INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).
ZENA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.3 | Oversold |
| Stochastic | 2.7 | Oversold |
ZENA's weekly RSI is 29 (oversold) and its Stochastic is 3 (oversold).
INTC PE vs Technology Sector
| Metric | INTC | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
INTC has no meaningful PE right now: it lost money over the past year.
ZENA PE vs Technology Sector
ZENA has no meaningful PE right now: it lost money over the past year.
INTC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.4 | 31% below |
| 20 week MA | $95.3 | 36% below |
| 50 week MA | $79.3 | 23% below |
| 100 week MA | $52.1 | 18% above |
| 200 week MA | $42.5 | 44% above |
INTC has stronger trend alignment. INTC is above 2 of 5 weekly averages versus ZENA above 0 of 4.
ZENA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.01 | 38% below |
| 20 week MA | $1.36 | 54% below |
| 50 week MA | $2.06 | 69% below |
| 100 week MA | $3.23 | 80% below |
ZENA is in a downtrend: it's below all four of its weekly moving averages, and 80% below its 100-week average.
INTC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.1 | $47.1 | -22% |
| 2021 | $47.1 | $51.3 | +9% |
| 2022 | $51.3 | $26.1 | -49% |
| 2023 | $26.1 | $50.3 | +93% |
| 2024 | $50.3 | $20.3 | -60% |
| 2025 | $20.3 | $36.2 | +78% |
| 2026 YTD | $36.2 | $61.2 | +69% |
INTC has the edge over ZENA on returns for 2026, with the stronger performance.
ZENA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $3.91 | $8.48 | +117% |
| 2025 | $8.48 | $3.42 | -60% |
| 2026 YTD | $3.42 | $0.63 | -82% |
ZENA's yearly returns have swung widely, from +117% in 2024 to −60% in 2025. It's down 82% so far in 2026.